PharmaShots | Incisive News in 3 Shots

Subscribe Now

advanced squamous cell carcinoma

Merck KGaA Sign an Exclusive Worldwide License Agreement with Debiopharm for Xevinapant

Merck KGaA Sign an Exclusive Worldwide License Agreement with Debiopharm for Xevinapant

March 2, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us